IL-21 promotes pulmonary fibrosis through the induction of profibrotic CD8+ T cells

Journal of Immunology

Volumn 195, Issue 11, 2015, Pages 5251-5260

  Brodeur, Tia Y ^a   Robidoux, Tara E ^a   Weinstein, Jason S ^b   Craft, Joseph ^b   Swain, Susan L ^a   Marshak Rothstein, Ann ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4; BLEOMYCIN; IL21R PROTEIN, MOUSE; INTERLEUKIN 21 RECEPTOR ALPHA; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROGENESIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TC2 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LUNG; LUNG FIBROSIS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

ANIMALS; BLEOMYCIN; CELL DIFFERENTIATION; CELLS, CULTURED; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-21 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; INTERLEUKINS; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84948769769     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500777     Document Type: Article

References (59)

1. Wynn, T. A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4: 583-594.
2. Wick, G., C. Grundtman, C. Mayerl, T. F. Wimpissinger, J. Feichtinger, B. Zelger, R. Sgonc, and D. Wolfram. 2013. The immunology of fibrosis. Annu. Rev. Immunol. 31: 107-135.
3. Wynn, T. A., and T. R. Ramalingam. 2012. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18: 1028-1040.
4. Wynn, T. A. 2011. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208: 1339-1350.
5. Luzina, I. G., N. W. Todd, A. T. Iacono, and S. P. Atamas. 2008. Roles of T lymphocytes in pulmonary fibrosis. J. Leukoc. Biol. 83: 237-244.
6. Lee, C. G., R. J. Homer, Z. Zhu, S. Lanone, X. Wang, V. Koteliansky, J. M. Shipley, P. Gotwals, P. Noble, Q. Chen, et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194: 809-821.
7. Wallace, V. A., S. Kondo, T. Kono, Z. Xing, E. Timms, C. Furlonger, E. Keystone, J. Gauldie, D. N. Sauder, T. W. Mak, et al. 1994. A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice. Eur. J. Immunol. 24: 1463-1466.
8. Radojcic, V., M. A. Pletneva, H. R. Yen, S. Ivcevic, A. Panoskaltsis-Mortari, A. C. Gilliam, C. G. Drake, B. R. Blazar, and L. Luznik. 2010. STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graftversus-host disease in a murine model. J. Immunol. 184: 764-774.
9. Pesce, J., M. Kaviratne, T. R. Ramalingam, R. W. Thompson, J. F. Urban, Jr., A. W. Cheever, D. A. Young, M. Collins, M. J. Grusby, and T. A. Wynn. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 116: 2044-2055.
10. Wilson, M. S., S. K. Madala, T. R. Ramalingam, B. R. Gochuico, I. O. Rosas, A. W. Cheever, and T. A. Wynn. 2010. Bleomycin and IL-1βeta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207: 535-552.
11. Fichtner-Feigl, S.,W. Strober, K. Kawakami, R. K. Puri, and A. Kitani. 2006. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGFbeta1 production and fibrosis. Nat. Med. 12: 99-106.
12. Belperio, J. A., M. Dy, M. D. Burdick, Y. Y. Xue, K. Li, J. A. Elias, and M. P. Keane. 2002. Interaction of IL-13 and C10 in the pathogenesis of bleomycininduced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 27: 419-427.
13. Jakubzick, C., E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam. 2003. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4-and IL-13-responsive cells. J. Immunol. 171: 2684-2693.
14. Miyahara, N., B. J. Swanson, K. Takeda, C. Taube, S. Miyahara, T. Kodama, A. Dakhama, V. L. Ott, and E. W. Gelfand. 2004. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat. Med. 10: 865-869.
15. Das, J., P. Eynott, R. Jupp, A. Bothwell, L. Van Kaer, Y. Shi, and G. Das. 2006. Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation. Nat. Med. 12: 1345-1346, author reply 1347.
16. Miyahara, N., K. Takeda, T. Kodama, A. Joetham, C. Taube, J. W. Park, S. Miyahara, A. Balhorn, A. Dakhama, and E. W. Gelfand. 2004. Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J. Immunol. 172: 2549-2558.
17. Dakhama, A., M. L. Collins, H. Ohnishi, E. Goleva, D. Y. Leung, R. Alam, E. R. Sutherland, R. J. Martin, and E. W. Gelfand. 2013. IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction. Allergy 68: 666-673.
18. Oh, K., H. B. Park, O. J. Byoun, D. M. Shin, E. M. Jeong, Y. W. Kim, Y. S. Kim, G. Melino, I. G. Kim, and D. S. Lee. 2011. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J. Exp. Med. 208: 1707-1719.
19. Spolski, R., and W. J. Leonard. 2008. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20: 295-301.
20. Liu, S. M., and C. King. 2013. IL-21-producing Th cells in immunity and autoimmunity. J. Immunol. 191: 3501-3506.
21. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
22. Fröhlich, A., B. J. Marsland, I. Sonderegger, M. Kurrer, M. R. Hodge, N. L. Harris, and M. Kopf. 2007. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109: 2023-2031.
23. Parrish-Novak, J., D. C. Foster, R. D. Holly, and C. H. Clegg. 2002. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol. 72: 856-863.
24. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
25. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
26. Shulman, Z., A. D. Gitlin, J. S. Weinstein, B. Lainez, E. Esplugues, R. A. Flavell, J. E. Craft, and M. C. Nussenzweig. 2014. Dynamic signaling by T follicular helper cells during germinal center B cell selection. Science 345: 1058-1062.
27. Walters, D. M., and S. R. Kleeberger. 2008. Mouse models of bleomycininduced pulmonary fibrosis. Curr. Protoc. Pharmacol. Chapter 5: Unit 5. 46.
28. Spolski, R., L. Wang, C. K. Wan, C. A. Bonville, J. B. Domachowske, H. P. Kim, Z. Yu, and W. J. Leonard. 2012. IL-21 promotes the pathologic immune response to pneumovirus infection. J. Immunol. 188: 1924-1932.
29. Kaviratne, M., M. Hesse, M. Leusink, A. W. Cheever, S. J. Davies, J. H. McKerrow, L. M. Wakefield, J. J. Letterio, and T. A. Wynn. 2004. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173: 4020-4029.
30. Helene, M., V. Lake-Bullock, J. Zhu, H. Hao, D. A. Cohen, and A. M. Kaplan. 1999. T cell independence of bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 65: 187-195.
31. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170: 655-663.
32. Shevach, E. M. 2009. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
33. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
34. Sad, S., R. Marcotte, and T. R. Mosmann. 1995. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2: 271-279.
35. Croft, M., L. Carter, S. L. Swain, and R. W. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180: 1715-1728.
36. Gur, I., R. Or, M. J. Segel, M. Shriki, G. Izbicki, and R. Breuer. 2000. Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and-resistant BALB/c mice. Exp. Lung Res. 26: 521-534.
37. Wei, L., A. Laurence, K. M. Elias, and J. J. O'Shea. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282: 34605-34610.
38. Rosada, R. S., A. P. Moreira, F. G. Frantz, R. K. Puri, A. Rahman, T. J. Standiford, C. R. Zárate-Bladés, C. L. Silva, and C. M. Hogaboam. 2010. Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A. PLoS One 5: e8721.
39. Cerwenka, A., T. M. Morgan, A. G. Harmsen, and R. W. Dutton. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189: 423-434.
40. Helmich, B. K., and R. W. Dutton. 2001. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J. Immunol. 166: 6500-6508.
41. Miyazaki, H., K. Kuwano, K. Yoshida, T. Maeyama, M. Yoshimi, M. Fujita, N. Hagimoto, R. Yoshida, and Y. Nakanishi. 2004. The perforin mediated apoptotic pathway in lung injury and fibrosis. J. Clin. Pathol. 57: 1292-1298.
42. Ciric, B., M. El-behi, R. Cabrera, G. X. Zhang, and A. Rostami. 2009. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J. Immunol. 182: 5296-5305.
43. Monteleone, G., R. Caruso, D. Fina, I. Peluso, V. Gioia, C. Stolfi, M. C. Fantini, F. Caprioli, R. Tersigni, L. Alessandroni, et al. 2006. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55: 1774-1780.
44. Rochman, Y., R. Spolski, and W. J. Leonard. 2009. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9: 480-490.
45. Wan, C. K., J. Oh, P. Li, E. E. West, E. A. Wong, A. B. Andraski, R. Spolski, Z. X. Yu, J. He, B. L. Kelsall, and W. J. Leonard. 2013. The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells. Immunity 38: 514-527.
46. Song, E., N. Ouyang, M. Hörbelt, B. Antus, M. Wang, and M. S. Exton. 2000. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204: 19-28.
47. Gibbons, M. A., A. C. MacKinnon, P. Ramachandran, K. Dhaliwal, R. Duffin, A. T. Phythian-Adams, N. van Rooijen, C. Haslett, S. E. Howie, A. J. Simpson, et al. 2011. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184: 569-581.
48. Pechkovsky, D. V., A. Prasse, F. Kollert, K. M. Engel, J. Dentler, W. Luttmann, K. Friedrich, J. Muller-Quernheim, and G. Zissel. 2010. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin. Immunol. 137: 89-101.
49. Duffield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115: 56-65.
50. Petrelli, A., M. Carvello, A. Vergani, K. M. Lee, S. Tezza, M. Du, S. Kleffel, L. Chengwen, B. G. Mfarrej, P. Hwu, et al. 2011. IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response. Diabetes 60: 3223-3234.
51. Attridge, K., C. J. Wang, L. Wardzinski, R. Kenefeck, J. L. Chamberlain, C. Manzotti, M. Kopf, and L. S. Walker. 2012. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 119: 4656-4664.
52. Schmitz, I., C. Schneider, A. Fröhlich, H. Frebel, D. Christ, W. J. Leonard, T. Sparwasser, A. Oxenius, S. Freigang, and M. Kopf. 2013. IL-21 restricts virusdriven Treg cell expansion in chronic LCMVinfection. PLoS Pathog. 9: e1003362.
53. Van Belle, T. L., S. Nierkens, R. Arens, and M. G. von Herrath. 2012. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 36: 1060-1072.
54. Atamas, S. P., V. V. Yurovsky, R. Wise, F. M. Wigley, C. J. Goter Robinson, P. Henry, W. J. Alms, and B. White. 1999. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum. 42: 1168-1178.
55. Radstake, T. R., L. van Bon, J. Broen, A. Hussiani, R. Hesselstrand, D. M. Wuttge, Y. Deng, R. Simms, E. Lubberts, and R. Lafyatis. 2009. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 4: e5903.
56. Fuschiotti, P., A. T. Larregina, J. Ho, C. Feghali-Bostwick, and T. A. Medsger, Jr. 2013. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 65: 236-246.
57. Fuschiotti, P., T. A. Medsger, Jr., and P. A. Morel. 2009. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum. 60: 1119-1128.
58. Kradin, R. L., M. B. Divertie, R. B. Colvin, J. Ramirez, J. Ryu, H. A. Carpenter, and A. K. Bhan. 1986. Usual interstitial pneumonitis is a T-cell alveolitis. Clin. Immunol. Immunopathol. 40: 224-235.
59. Papiris, S. A., A. Kollintza, P. Kitsanta, G. Kapotsis, M. Karatza, J. Milic-Emili, C. Roussos, and Z. Daniil. 2005. Relationship of BAL and lung tissue CD4+ and CD8+ T lymphocytes, and their ratio in idiopathic pulmonary fibrosis. Chest 128: 2971-2977.